| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TScan Therapeutics, Inc. | Director | Voting Common Stock | 45K | $238K | $5.29 | Sep 23, 2024 | Direct |
| TScan Therapeutics, Inc. | Director | Voting Common Stock | 30K | $149K | $4.97 | Dec 14, 2023 | Direct |
| Xencor Inc | Director | Common Stock | 5.99K | $141K | $23.58 | Jun 13, 2024 | Direct |
| TScan Therapeutics, Inc. | Director | Voting Common Stock | 25K | $132K | $5.29 | Sep 23, 2024 | By Trust |
| TScan Therapeutics, Inc. | Director | Voting Common Stock | 25K | $124K | $4.97 | Dec 14, 2023 | By Trust |
| TScan Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 47.5K | Jun 12, 2024 | Direct | ||
| Xencor Inc | Director | Stock Option (Right to Buy) | 12K | Jun 13, 2024 | Direct | ||
| eFFECTOR Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 800 | Jun 13, 2024 | Direct | ||
| Sierra Oncology, Inc. | Chief Medical Officer | Common Stock | 0 | $55.00 | Jul 1, 2022 | By spouse | |
| Sierra Oncology, Inc. | Chief Medical Officer | Common Stock | 0 | $55.00 | Jul 1, 2022 | Direct | |
| Sierra Oncology, Inc. | Chief Medical Officer | Stock Option (right to buy) | 0 | Jul 1, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | Sep 23, 2024 | 1 | $26.5K | 4 | Sep 24, 2024 | Director |
| TCRX | TScan Therapeutics, Inc. | Aug 23, 2024 | 2 | $56.1K | 4 | Aug 27, 2024 | Director |
| XNCR | Xencor Inc | Jun 13, 2024 | 2 | $0 | 4 | Jun 17, 2024 | Director |
| EFTR | eFFECTOR Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
| TCRX | TScan Therapeutics, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| EFTR | eFFECTOR Therapeutics, Inc. | Feb 19, 2024 | 1 | $0 | 4 | Feb 21, 2024 | Director |
| TCRX | TScan Therapeutics, Inc. | Dec 14, 2023 | 1 | $25.4K | 4 | Dec 18, 2023 | Director |
| XNCR | Xencor Inc | Sep 15, 2023 | 1 | $0 | 4 | Sep 19, 2023 | Director |
| XNCR | Xencor Inc | Sep 15, 2023 | 0 | $0 | 3 | Sep 19, 2023 | Director |
| EFTR | eFFECTOR Therapeutics, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 22, 2023 | Director |
| TCRX | TScan Therapeutics, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
| TCRX | TScan Therapeutics, Inc. | Apr 6, 2023 | 1 | $0 | 4 | Apr 10, 2023 | Director |
| TCRX | TScan Therapeutics, Inc. | Apr 6, 2023 | 0 | $0 | 3 | Apr 10, 2023 | Director |
| EFTR | eFFECTOR Therapeutics, Inc. | Jan 20, 2023 | 1 | $0 | 4 | Jan 24, 2023 | Director |
| SRRA | Sierra Oncology, Inc. | Jul 1, 2022 | 12 | -$825K | 4 | Jul 1, 2022 | Chief Medical Officer |
| SRRA | Sierra Oncology, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Chief Medical Officer |
| EFTR | eFFECTOR Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| SRRA | Sierra Oncology, Inc. | Mar 14, 2022 | 1 | $0 | 4 | Mar 14, 2022 | Chief Medical Officer |
| SRRA | Sierra Oncology, Inc. | Jan 28, 2022 | 1 | $0 | 4 | Jan 28, 2022 | Chief Medical Officer |
| EFTR | eFFECTOR Therapeutics, Inc. | Nov 1, 2021 | 1 | $0 | 4 | Nov 2, 2021 | Director |
| EFTR | eFFECTOR Therapeutics, Inc. | Nov 1, 2021 | 0 | $0 | 3 | Nov 2, 2021 | Director |